Cover Image

Weight Changes From Glucagon‐Like Peptide‐1 Receptor Agonist Use and Discontinuation: A Retrospective Cohort Study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	G. Caleb Alexander, Yizhen Xu, Xuya Xiao, Sydney V. Lewis, Scott Zeger, Hemalkumar B. Mehta
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Obesity
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study
by: Arvid Engström, et al.
Published: (2026)

Glucagon‐Like Peptide‐1 Receptor Agonists: Considerations for Treating Preconception Obesity
by: Lauren T. Berube, et al.
Published: (2026)

Effect of Glucagon‐Like Peptide 1 Receptor Agonists on Obstructive Sleep Apnea
by: Bei‐Bei Qian, et al.
Published: (2025)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
by: Hezekiah C. T. Au, et al.
Published: (2026)

Obesity and Female Reproductive Health; Is There a Role for Glucagon‐Like Peptide‐1 Receptor Agonists?
by: Rachel Roberts, et al.
Published: (2025)

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults
by: Jie‐Syuan Wu, et al.
Published: (2026)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes
by: Ying Lu, et al.
Published: (2025)

Association Between Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
by: Timothy H. Chan, et al.
Published: (2026)

Association of Glucagon‐Like Peptide Agonist Therapy With Dietary Patterns in a Cross‐Sectional Cohort
by: Eric J. Brandt, et al.
Published: (2025)

How Bioethics and Reproductive Justice Ought to Inform Glucagon‐Like Peptide‐1 Receptor Agonists, Research, and Pregnancy
by: Nishita Pondugula, et al.
Published: (2025)

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists (Mono and Combination Therapy) on Energy Expenditure: A Scoping Review
by: Flavio T. Vieira, et al.
Published: (2026)

Association of Glucagon‐Like Peptide‐1 Receptor Agonist Use With Risk of Psychiatric Disorders: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
by: Shumeng Han, et al.
Published: (2026)

Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
by: Roberta Scairati, et al.
Published: (2026)

Adherence and Persistence Among Individuals Living With Type 2 Diabetes and Using a Free Combination of Basal Insulin and an Injectable Glucagon‐Like Peptide‐1 Receptor Agonist Versus a Fixed‐Ratio Combination Therapy: A Japanese Database Study
by: Takeshi Miyatsuka, et al.
Published: (2026)

Efficacy and Safety of GLP ‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
by: Binayak Sinha, et al.
Published: (2025)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
by: Giorgia Rutigliani, et al.
Published: (2026)

Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study
by: Harold E. Bays, et al.
Published: (2026)

Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis
by: Matheus Souza, et al.
Published: (2026)

GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
by: Hao Dai, et al.
Published: (2025)

One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment
by: Joachim Holt, et al.
Published: (2025)

GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs
by: Jirawan Vienghirun, et al.
Published: (2026)

Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
by: Tahmid Hussain, et al.
Published: (2026)

Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery
by: Amanda Finn, et al.
Published: (2025)

Targeting central pathway of Glucose‐Dependent Insulinotropic Polypeptide, Glucagon and Glucagon‐like Peptide‐1 for metabolic regulation in obesity and type 2 diabetes
by: Zhimin Xu, et al.
Published: (2024)

GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation
by: Haisheng Wu, et al.
Published: (2026)

Cardiometabolic Profiles and Treatment Trajectories of GLP ‐1 Receptor Agonist Users With Obstructive Sleep Apnea: Real‐World Evidence From a Large Private Healthcare Cohort in Poland
by: Klaudia Nowak, et al.
Published: (2026)

GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
by: Hiba Jebeile, et al.
Published: (2025)

Combining GLP ‐1 Receptor Agonists and Health‐Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real‐World Single‐Center Study
by: Julia Lischka, et al.
Published: (2026)

Micronutrient and Nutritional Deficiencies Associated With GLP ‐1 Receptor Agonist Therapy: A Narrative Review
by: Jorge Urbina, et al.
Published: (2026)

Weight Loss With GLP ‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis
by: Michael Lim, et al.
Published: (2026)

Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression
by: Muhammad Tahir, et al.
Published: (2026)

Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
by: Inyoung Hwang, et al.
Published: (2026)

Holiday Weight Change in a US College Student Sample: A Prospective Observational Cohort Study
by: Hannah B. Yoo, et al.
Published: (2025)

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP ‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials
by: Lucas Sabatella, et al.
Published: (2025)

Determinants of Parents' and Adolescents' Motivation Before Pediatric Weight Management—Data From the STARKIDS Cohort
by: Anne Herschbach, et al.
Published: (2026)

GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
by: Cynthia F. X. C. A. Silva, et al.
Published: (2026)

GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study
by: Dina H. Griauzde, et al.
Published: (2026)

Association Between Metabolic Syndrome and Incident Cervical Cancer: A Retrospective Cohort Study
by: Linjun Jiang, et al.
Published: (2025)

Identifying Predictors of Early Treatment Intensification in Individuals With Type 2 Diabetes Treated With GLP ‐1 Receptor Agonists: A Machine Learning–Based Analysis of a Large Real World Cohort
by: Pierpaolo Falcetta, et al.
Published: (2026)

Glucagon‐like peptide‐1 receptor agonists and incidence of obesity‐related cancer in adults with diabetes: A target‐trial emulation study
by: Lucas A. Mavromatis, et al.
Published: (2025)